COP
36
2
AXP
63
3
LRCX
56
4
CCI
30
2
KLAC
45
3
TMO
52
8
PNR
56
2
FMC
23
7
FOX
71
3
MDLZ
28
2
MU
42
14
ALL
37
3
FIS
43
5
EMC
30
-26
IVZ
42
13
HIG
48
5
TRV
34
4
STZ
42
2
NDAQ
46
2
TROW
37
8
COP
36
2
AXP
63
3
LRCX
56
4
CCI
30
2
KLAC
45
3
TMO
52
8
PNR
56
2
FMC
23
7
FOX
71
3
MDLZ
28
2
MU
42
14
ALL
37
3
FIS
43
5
EMC
30
-26
IVZ
42
13
HIG
48
5
TRV
34
4
STZ
42
2
NDAQ
46
2
TROW
37
8
Financhill
Back

The Cooper Companies 10K Form

Buy
63

COO
The Cooper Companies

Last Price:
$92.48
Seasonality Move:
10.1%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive COO News And Ratings

See the #1 stock for the next 7 days that we like better than COO

COO Financial Statistics

Sales & Book Value

Annual Sales: $3.9B
Cash Flow: $128.1M
Price / Cash Flow: 65
Annual Sales: $40.50
Price / Book: 2.31

Profitability

EPS (TTM): 1.95000
Net Income (TTM): $392.3M
Gross Margin: $2.6B
Return on Equity: 5.02%
Return on Assets: 3.26%

The Cooper Companies Earnings Forecast

Key The Cooper Companies Financial Ratios

  • The Gross Profit Margin over the past 41 years for COO is 66.64%.
  • The Selling, General & Administrative Expenses for COO have been equal to 39.37% of Gross Profit Margin.
  • The Research & Development expenses have been 3.98% of Revenue.
  • The Interest Expense is 29.14% of Operating Income.
  • The Net Earning history of COO is 10.07% of Total Revenues.
  • Per Share Earnings over the last 41 years have been positive in 27 years.

The Cooper Companies Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Health Care Equipment & Supplies
Sector: Health Care
Current Symbol: COO
CUSIP: 216648
Website: coopercos.com

Debt

Debt-to-Equity Ratio: 0.32
Current Ratio: 1.91
Quick Ratio: 0.81

Price-to-Earnings

Trailing P/E Ratio: 47.67
Forward P/E Ratio: 21.06

COO Technical Analysis vs Fundamental Analysis

Buy
63
The Cooper Companies (COO) is a Buy

Is The Cooper Companies a Buy or a Sell?